David Lawrence
2015
In 2015, David Lawrence earned a total compensation of $1.2M as Chief, Business Operations and Principal Accounting Officer at Acorda Therapeutics, a 14% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $164,165 |
|---|---|
| Option Awards | $507,514 |
| Salary | $351,783 |
| Stock Awards | $199,179 |
| Other | $7,950 |
| Total | $1,230,591 |
Lawrence received $507.5K in option awards, accounting for 41% of the total pay in 2015.
Lawrence also received $164.2K in non-equity incentive plan, $351.8K in salary, $199.2K in stock awards and $8K in other compensation.
Rankings
In 2015, David Lawrence's compensation ranked 6,932nd out of 13,638 executives tracked by ExecPay. In other words, Lawrence earned more than 49.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,932 out of 13,638 | 49th |
Division Manufacturing | 2,623 out of 5,190 | 50th |
Major group Chemicals And Allied Products | 940 out of 1,854 | 49th |
Industry group Drugs | 755 out of 1,528 | 51st |
Industry Biological Products, Except Diagnostic Substances | 133 out of 254 | 48th |
Source: SEC filing on April 21, 2017.
Lawrence's colleagues
We found six more compensation records of executives who worked with David Lawrence at Acorda Therapeutics in 2015.
2015
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2015
Jane Wasman
Acorda Therapeutics
General Counsel
2015
Enrique Carrazana
Acorda Therapeutics
Chief Medical Officer
2015
Michael Rogers
Acorda Therapeutics
Chief Financial Officer
2015
Lauren Sabella
Acorda Therapeutics
Chief Commercial Officer
2015
Andrew Hindman
Acorda Therapeutics